nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—DRD2—Gilles de la Tourette syndrome	0.823	1	CbGaD
Sumatriptan—MAOA—Clearance of dopamine—SLC6A3—Gilles de la Tourette syndrome	0.00916	0.0674	CbGpPWpGaD
Sumatriptan—MAOA—Biogenic Amine Synthesis—HDC—Gilles de la Tourette syndrome	0.00727	0.0535	CbGpPWpGaD
Sumatriptan—DRD2—Dopamine receptors—DRD3—Gilles de la Tourette syndrome	0.00494	0.0363	CbGpPWpGaD
Sumatriptan—DRD2—Dopamine receptors—DRD4—Gilles de la Tourette syndrome	0.00479	0.0353	CbGpPWpGaD
Sumatriptan—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.00418	0.0308	CbGpPWpGaD
Sumatriptan—HTR1F—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.00371	0.0273	CbGpPWpGaD
Sumatriptan—HTR1F—nervous system—Gilles de la Tourette syndrome	0.00308	0.0743	CbGeAlD
Sumatriptan—HTR1F—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00306	0.0225	CbGpPWpGaD
Sumatriptan—HTR1F—central nervous system—Gilles de la Tourette syndrome	0.00297	0.0715	CbGeAlD
Sumatriptan—HTR1F—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00261	0.0192	CbGpPWpGaD
Sumatriptan—HTR1F—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00253	0.0186	CbGpPWpGaD
Sumatriptan—HTR1D—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.00237	0.0174	CbGpPWpGaD
Sumatriptan—HTR1F—brain—Gilles de la Tourette syndrome	0.00236	0.0568	CbGeAlD
Sumatriptan—HTR1F—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00236	0.0173	CbGpPWpGaD
Sumatriptan—HTR1B—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.00232	0.0171	CbGpPWpGaD
Sumatriptan—HTR1F—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00219	0.0161	CbGpPWpGaD
Sumatriptan—HTR1F—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00213	0.0156	CbGpPWpGaD
Sumatriptan—HTR1F—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00198	0.0146	CbGpPWpGaD
Sumatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00195	0.0144	CbGpPWpGaD
Sumatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00191	0.0141	CbGpPWpGaD
Sumatriptan—HTR1A—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.00177	0.013	CbGpPWpGaD
Sumatriptan—HTR1D—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00167	0.0123	CbGpPWpGaD
Sumatriptan—HTR1F—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00165	0.0121	CbGpPWpGaD
Sumatriptan—HTR1B—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00163	0.012	CbGpPWpGaD
Sumatriptan—HTR1D—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00162	0.0119	CbGpPWpGaD
Sumatriptan—HTR1B—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00158	0.0117	CbGpPWpGaD
Sumatriptan—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.00157	0.0115	CbGpPWpGaD
Sumatriptan—HTR1B—midbrain—Gilles de la Tourette syndrome	0.00154	0.037	CbGeAlD
Sumatriptan—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.00152	0.0112	CbGpPWpGaD
Sumatriptan—HTR1D—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00151	0.0111	CbGpPWpGaD
Sumatriptan—HTR3A—nervous system—Gilles de la Tourette syndrome	0.00151	0.0363	CbGeAlD
Sumatriptan—HTR1D—midbrain—Gilles de la Tourette syndrome	0.00149	0.0359	CbGeAlD
Sumatriptan—HTR1B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00148	0.0109	CbGpPWpGaD
Sumatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00146	0.0107	CbGpPWpGaD
Sumatriptan—HTR3A—central nervous system—Gilles de la Tourette syndrome	0.00145	0.0349	CbGeAlD
Sumatriptan—SLCO1A2—midbrain—Gilles de la Tourette syndrome	0.00145	0.0348	CbGeAlD
Sumatriptan—HTR1D—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0014	0.0103	CbGpPWpGaD
Sumatriptan—HTR1F—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00139	0.0102	CbGpPWpGaD
Sumatriptan—HTR1B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00137	0.0101	CbGpPWpGaD
Sumatriptan—HTR1D—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00136	0.01	CbGpPWpGaD
Sumatriptan—HTR1B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00133	0.0098	CbGpPWpGaD
Sumatriptan—DRD2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00128	0.00942	CbGpPWpGaD
Sumatriptan—HTR1D—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00127	0.00932	CbGpPWpGaD
Sumatriptan—HTR1B—nervous system—Gilles de la Tourette syndrome	0.00126	0.0304	CbGeAlD
Sumatriptan—HTR1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00124	0.00915	CbGpPWpGaD
Sumatriptan—HTR1B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00124	0.00913	CbGpPWpGaD
Sumatriptan—HTR1A—midbrain—Gilles de la Tourette syndrome	0.00124	0.0299	CbGeAlD
Sumatriptan—HTR1D—nervous system—Gilles de la Tourette syndrome	0.00122	0.0295	CbGeAlD
Sumatriptan—HTR1B—central nervous system—Gilles de la Tourette syndrome	0.00122	0.0293	CbGeAlD
Sumatriptan—HTR1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00121	0.00888	CbGpPWpGaD
Sumatriptan—SLCO1A2—nervous system—Gilles de la Tourette syndrome	0.00119	0.0286	CbGeAlD
Sumatriptan—HTR1D—central nervous system—Gilles de la Tourette syndrome	0.00118	0.0284	CbGeAlD
Sumatriptan—HTR1F—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00116	0.00852	CbGpPWpGaD
Sumatriptan—HTR3A—brain—Gilles de la Tourette syndrome	0.00115	0.0277	CbGeAlD
Sumatriptan—SLCO1A2—central nervous system—Gilles de la Tourette syndrome	0.00114	0.0276	CbGeAlD
Sumatriptan—MAOA—midbrain—Gilles de la Tourette syndrome	0.00113	0.0273	CbGeAlD
Sumatriptan—HTR1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00112	0.00827	CbGpPWpGaD
Sumatriptan—HTR1F—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00112	0.00827	CbGpPWpGaD
Sumatriptan—DRD2—midbrain—Gilles de la Tourette syndrome	0.00112	0.027	CbGeAlD
Sumatriptan—DRD2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00109	0.00803	CbGpPWpGaD
Sumatriptan—DRD2—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.00109	0.00799	CbGpPWpGaD
Sumatriptan—DRD2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00106	0.0078	CbGpPWpGaD
Sumatriptan—HTR1D—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00106	0.00777	CbGpPWpGaD
Sumatriptan—HTR1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00104	0.00769	CbGpPWpGaD
Sumatriptan—HTR1B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00103	0.0076	CbGpPWpGaD
Sumatriptan—HTR1A—nervous system—Gilles de la Tourette syndrome	0.00102	0.0246	CbGeAlD
Sumatriptan—HTR1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00101	0.00746	CbGpPWpGaD
Sumatriptan—ABCG2—midbrain—Gilles de la Tourette syndrome	0.000982	0.0237	CbGeAlD
Sumatriptan—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000982	0.0237	CbGeAlD
Sumatriptan—HTR1B—brain—Gilles de la Tourette syndrome	0.000966	0.0233	CbGeAlD
Sumatriptan—HTR1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000945	0.00695	CbGpPWpGaD
Sumatriptan—HTR1D—brain—Gilles de la Tourette syndrome	0.000935	0.0225	CbGeAlD
Sumatriptan—MAOA—nervous system—Gilles de la Tourette syndrome	0.000932	0.0224	CbGeAlD
Sumatriptan—DRD2—nervous system—Gilles de la Tourette syndrome	0.000921	0.0222	CbGeAlD
Sumatriptan—DRD2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000917	0.00675	CbGpPWpGaD
Sumatriptan—SLCO1A2—brain—Gilles de la Tourette syndrome	0.000909	0.0219	CbGeAlD
Sumatriptan—MAOA—central nervous system—Gilles de la Tourette syndrome	0.000897	0.0216	CbGeAlD
Sumatriptan—DRD2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000891	0.00655	CbGpPWpGaD
Sumatriptan—HTR1D—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000887	0.00653	CbGpPWpGaD
Sumatriptan—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000887	0.0214	CbGeAlD
Sumatriptan—HTR1B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000869	0.00639	CbGpPWpGaD
Sumatriptan—HTR1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000787	0.00579	CbGpPWpGaD
Sumatriptan—HTR1A—brain—Gilles de la Tourette syndrome	0.000779	0.0188	CbGeAlD
Sumatriptan—HTR1F—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.000733	0.00539	CbGpPWpGaD
Sumatriptan—MAOA—brain—Gilles de la Tourette syndrome	0.000712	0.0172	CbGeAlD
Sumatriptan—DRD2—brain—Gilles de la Tourette syndrome	0.000704	0.017	CbGeAlD
Sumatriptan—DRD2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000691	0.00509	CbGpPWpGaD
Sumatriptan—HTR1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000662	0.00487	CbGpPWpGaD
Sumatriptan—ABCG2—brain—Gilles de la Tourette syndrome	0.000617	0.0149	CbGeAlD
Sumatriptan—DRD2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000581	0.00428	CbGpPWpGaD
Sumatriptan—HTR1F—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000542	0.00399	CbGpPWpGaD
Sumatriptan—HTR1F—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000526	0.00387	CbGpPWpGaD
Sumatriptan—HTR3A—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000523	0.00385	CbGpPWpGaD
Sumatriptan—HTR1F—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000503	0.0037	CbGpPWpGaD
Sumatriptan—HTR1F—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00049	0.00361	CbGpPWpGaD
Sumatriptan—HTR1F—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000488	0.00359	CbGpPWpGaD
Sumatriptan—ABCB1—midbrain—Gilles de la Tourette syndrome	0.000484	0.0117	CbGeAlD
Sumatriptan—HTR1F—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000455	0.00335	CbGpPWpGaD
Sumatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000431	0.00317	CbGpPWpGaD
Sumatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000418	0.00308	CbGpPWpGaD
Sumatriptan—ABCB1—nervous system—Gilles de la Tourette syndrome	0.000398	0.00959	CbGeAlD
Sumatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00039	0.00287	CbGpPWpGaD
Sumatriptan—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.000383	0.00924	CbGeAlD
Sumatriptan—HTR1D—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000347	0.00255	CbGpPWpGaD
Sumatriptan—HTR1B—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000339	0.0025	CbGpPWpGaD
Sumatriptan—HTR1D—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000336	0.00248	CbGpPWpGaD
Sumatriptan—HTR1B—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000329	0.00242	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000328	0.00241	CbGpPWpGaD
Sumatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000322	0.00237	CbGpPWpGaD
Sumatriptan—HTR1F—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000319	0.00234	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000318	0.00234	CbGpPWpGaD
Sumatriptan—MAOA—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.000318	0.00234	CbGpPWpGaD
Sumatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000315	0.00232	CbGpPWpGaD
Sumatriptan—HTR1D—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000313	0.00231	CbGpPWpGaD
Sumatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000312	0.0023	CbGpPWpGaD
Sumatriptan—HTR1B—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000307	0.00226	CbGpPWpGaD
Sumatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000306	0.00225	CbGpPWpGaD
Sumatriptan—ABCB1—brain—Gilles de la Tourette syndrome	0.000304	0.00733	CbGeAlD
Sumatriptan—HTR1F—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000297	0.00218	CbGpPWpGaD
Sumatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000291	0.00214	CbGpPWpGaD
Sumatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000285	0.0021	CbGpPWpGaD
Sumatriptan—SLCO1A2—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.000279	0.00205	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000276	0.00203	CbGpPWpGaD
Sumatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000273	0.00201	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00027	0.00199	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000267	0.00197	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000267	0.00197	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000262	0.00193	CbGpPWpGaD
Sumatriptan—HTR1A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000258	0.0019	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000257	0.00189	CbGpPWpGaD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000256	0.00189	CbGpPWpGaD
Sumatriptan—HTR1A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000251	0.00185	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00025	0.00184	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000249	0.00183	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000244	0.0018	CbGpPWpGaD
Sumatriptan—MAOA—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000244	0.00179	CbGpPWpGaD
Sumatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00024	0.00177	CbGpPWpGaD
Sumatriptan—SLCO1B1—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.000238	0.00175	CbGpPWpGaD
Sumatriptan—HTR1A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000234	0.00172	CbGpPWpGaD
Sumatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000233	0.00171	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000227	0.00167	CbGpPWpGaD
Sumatriptan—DRD2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000227	0.00167	CbGpPWpGaD
Sumatriptan—DRD2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00022	0.00162	CbGpPWpGaD
Sumatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000217	0.0016	CbGpPWpGaD
Sumatriptan—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000211	0.00155	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00021	0.00154	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000208	0.00153	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000206	0.00151	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000205	0.00151	CbGpPWpGaD
Sumatriptan—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000204	0.0015	CbGpPWpGaD
Sumatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000204	0.0015	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000204	0.0015	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0002	0.00147	CbGpPWpGaD
Sumatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000199	0.00147	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000199	0.00147	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—HDC—Gilles de la Tourette syndrome	0.000191	0.0014	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00019	0.0014	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000186	0.00137	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000186	0.00137	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000185	0.00136	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00018	0.00133	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00018	0.00132	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—HDC—Gilles de la Tourette syndrome	0.000177	0.0013	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000175	0.00129	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000175	0.00128	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000171	0.00126	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000168	0.00124	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000168	0.00123	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000163	0.0012	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—HDC—Gilles de la Tourette syndrome	0.000163	0.0012	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000156	0.00115	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000152	0.00112	CbGpPWpGaD
Sumatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000152	0.00112	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000152	0.00112	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—HDC—Gilles de la Tourette syndrome	0.000151	0.00111	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000142	0.00104	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000142	0.00104	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000137	0.00101	CbGpPWpGaD
Sumatriptan—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000133	0.000982	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000133	0.000982	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000133	0.000978	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00013	0.000958	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00013	0.000957	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000121	0.000891	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000119	0.000872	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000117	0.000864	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000116	0.000854	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000115	0.000847	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000114	0.000841	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000113	0.000829	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000112	0.000825	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000108	0.000792	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000107	0.000789	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000107	0.000785	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000105	0.000776	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000105	0.000773	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000105	0.000769	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000102	0.000753	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	9.95e-05	0.000732	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	9.91e-05	0.000729	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	9.74e-05	0.000717	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	9.66e-05	0.00071	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	9.53e-05	0.000702	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	8.99e-05	0.000662	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.84e-05	0.000651	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	8.7e-05	0.00064	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.59e-05	0.000632	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	8.16e-05	0.0006	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	8.03e-05	0.000591	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	8e-05	0.000589	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.8e-05	0.000574	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	7.76e-05	0.000571	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.54e-05	0.000555	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	7.51e-05	0.000553	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	7.35e-05	0.000541	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	7.26e-05	0.000534	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.05e-05	0.000519	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.85e-05	0.000504	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	6.82e-05	0.000502	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	6.68e-05	0.000491	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	6.36e-05	0.000468	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	6.3e-05	0.000464	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	6.23e-05	0.000458	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	6.17e-05	0.000454	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	6.06e-05	0.000446	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	6.05e-05	0.000445	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.75e-05	0.000423	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	5.63e-05	0.000414	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.6e-05	0.000412	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.09e-05	0.000374	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.92e-05	0.000362	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.74e-05	0.000349	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.61e-05	0.000339	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.47e-05	0.000329	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.29e-05	0.000316	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.17e-05	0.000307	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.04e-05	0.000298	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	4.03e-05	0.000296	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.94e-05	0.00029	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.01e-05	0.000221	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.64e-05	0.000194	CbGpPWpGaD
